The nitroxyl donor isopropylamine-NONOate elicits soluble guanylyl cyclase-dependent antihypertrophic actions: comparison of the potential therapeutic advantages of HNO over NO•

Documenti analoghi

• The novel NO redox sibling, nitroxyl (HNO), prevents cardiomyocyte hypertrophy and superoxide generation via cGMP
  di: Ritchie, Rebecca, et al.
  Pubblicazione: (2009)
• Nitroxyl (HNO) Stimulates Soluble Guanylyl Cyclase to Suppress Cardiomyocyte Hypertrophy and Superoxide Generation
  di: Lin, Eliane Q., et al.
  Pubblicazione: (2012)
• Antihypertrophic actions of NO-independent soluble guanylyl cyclase (sGC) ligands BAY 41-2272 and BAY 58-2667 in vitro
  di: Ritchie, Rebecca, et al.
  Pubblicazione: (2009)
• Soluble guanylyl cyclase mediates concomitant coronary vasodilator and positive inotropic actions of the HNO donor Angeli's salt in the intact rat heart
  di: Ritchie, Rebecca, et al.
  Pubblicazione: (2013)
• The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms
  di: Chin, Kai Yee, et al.
  Pubblicazione: (2014)